Tolerance of Inactivated SARS-CoV-2 Vaccine for People Living with HIV: A Real-World Evidence Analysis from a Retrospective Cohort Study
Our study suggests that inactivated SARS-CoV-2 vaccines do not adversely affect the risk of HIV viral rebound and were well-tolerated in PLWH.
Authors
- Zhen Ni (ORCID: https://orcid.org/0000-0002-3081-2830)
- Zhou Tao (ORCID: https://orcid.org/0000-0003-0323-9917)
- Mingjian Ni (ORCID: https://orcid.org/0009-0006-0275-7914)
- Jing Chen (ORCID: https://orcid.org/0000-0002-3987-0009)
- Kai Wang (ORCID: https://orcid.org/0000-0002-4464-4962)
- Ying Feng
- Qian He
- Ning Zhang (ORCID: https://orcid.org/0000-0002-4574-9256)
- Yuefei Li (ORCID: https://orcid.org/0000-0002-7251-8584)
- Shi Zhao
Institutions
- Xinjiang Medical University (CN)
- Maternal and Child Health Hospital of Xinjiang Uygur Autonomous Region (CN)
- Xinjiang Uygur Autonomous Region Disease Prevention and Control Center (CN)
- People's Hospital of Xinjiang Uygur Autonomous Region (CN)
Publication Details
- Journal
- Journal of Epidemiology and Global Health
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1007/s44197-025-00452-4
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Tianjin Medical University
- National Science and Technology Major Project